Reported to Head of Strategic Partnerships & Solutions. Total number of employees at company: 350. Working in agile methodology on design, test and deployment of new innovative technologies and initiatives across therapeutic areas such as cardiovascular, immunology, neuroscience and oncology to reduce inefficiencies in Australian healthcare system, I.e. accelerating time to diagnosis or time to treatment time, ensuring a better customer experience for patients. The role required agility and… Show more Reported to Head of Strategic Partnerships & Solutions. Total number of employees at company: 350. Working in agile methodology on design, test and deployment of new innovative technologies and initiatives across therapeutic areas such as cardiovascular, immunology, neuroscience and oncology to reduce inefficiencies in Australian healthcare system, I.e. accelerating time to diagnosis or time to treatment time, ensuring a better customer experience for patients. The role required agility and collaborative ways of working to enable effective team work across a matrix environment, to build impactful solutions within the healthcare system, based on customer needs. Scope could include expansion of existing solutions, co-creation of new solutions for either in-line, pipeline or addressing scalable solutions.Some achievements include:- Received award for learning and partnerships commitment. Recently provided coaching and subject matter expertise to the established brands team, upskilling portfolio managers during transition to focus on the hospital channel.- Managing cross functional stakeholder alignment and sign offs to test and scale digital innovative heart failure solution to 4000 General Practitioner practices and meeting the business unit expectations on the implementation timeline. The innovative solution is resulting in thousands of lost HF patients will be found and optimally treated with accurate General Practitioner records- Test and implemented application with features highlighting when the patient in consultation has potential signs and symptoms of inflammatory backpain which accelerates time to right diagnosis Show less

Reported to Oncology Sales and Marketing Lead. Total number of employees at division: 120Develop and implement brand strategies for established Solid Tumour and Haematology assets in in assigned territory (NSW, ACT, SA, WA). This entailed building strategic partnerships with key hospital accounts to drive sales, promotion and development in the designated accounts. Lead individual tactical plans and provided strategic direction in terms of analysis, future potential and key programs… Show more Reported to Oncology Sales and Marketing Lead. Total number of employees at division: 120Develop and implement brand strategies for established Solid Tumour and Haematology assets in in assigned territory (NSW, ACT, SA, WA). This entailed building strategic partnerships with key hospital accounts to drive sales, promotion and development in the designated accounts. Lead individual tactical plans and provided strategic direction in terms of analysis, future potential and key programs required for the accounts. Analyzed market situation including competitive intelligence activities and furthermore collaborated with marketing/medical department to organize customer events in line with agreed business tactical plans.Highlights include: - Successfully collaborated and negotiated with hospital treating- and executive teams at major hospitals and private hospital groups to maintain market share on molecules after generic entry/loss of exclusivity, and achieved performance 40% above budget.- Fostered relationships in major accounts for oncology and pharmaceutical divisions with directors of pharmacy, procurement heads at state health, key commercial, and customer engagement for key state tender submissions. Show less

Reported to Business Unit Director, Biopharma & Hospital. Total number of employees at company: 100. Develop commercial and tactical plans to secure strategic tender business in Australia and drive focus areas of portfolio, commercial operations and product launches (generics and biosimilars).Awards and recognitions:- Field Force Team of The Year- Team of the Year, Riximyo (rituximab) Launch. Highest market shares of a biosimilar launch in Sandoz globally. - Performance… Show more Reported to Business Unit Director, Biopharma & Hospital. Total number of employees at company: 100. Develop commercial and tactical plans to secure strategic tender business in Australia and drive focus areas of portfolio, commercial operations and product launches (generics and biosimilars).Awards and recognitions:- Field Force Team of The Year- Team of the Year, Riximyo (rituximab) Launch. Highest market shares of a biosimilar launch in Sandoz globally. - Performance Management, Managing Pipertaz undersupply risk - bravissimo award for securing strategic business Show less

Reported to Chief Finance Officer. Total number of employees at company: 100 Leading hospital tenders in Australia and drive improvement of margins. Focus on key accounts, successful new product launches, price strategies and cost control related to public and private tenders.Award and recognitions:- Curiosity & Learning Award- Nominated to Best in Class Award

Reported to National Business Manager, Hospital & Biopharma. Total number of employees: 100 Managing portfolio of Hospital & Biopharma Business products and driving new product launches, i.e. through price strategies and hospital tenders (public and private).Award and recognitions:- Quest award winner: Collaboration Ambassador - Sales Team of the year

Reported to Strategy and Planning Lead for Established Medicines Division. Total number of employees in division: 80Hired on a contract in relation to a project. The target was to create a foundation that enabled certain financial evaluations and strategic decisions in Pfizer Australia.- The tasks are related to the market dynamics of the pharmaceutical competitive landscape in Australia. I.e: Competition after LOE, where generics enter the marketReimbursement and SPD price… Show more Reported to Strategy and Planning Lead for Established Medicines Division. Total number of employees in division: 80Hired on a contract in relation to a project. The target was to create a foundation that enabled certain financial evaluations and strategic decisions in Pfizer Australia.- The tasks are related to the market dynamics of the pharmaceutical competitive landscape in Australia. I.e: Competition after LOE, where generics enter the marketReimbursement and SPD price cutsEvaluation of market opportunities -Reporting to senior management team to support strategic business decisions. Show less

Reported to Country Manager. Total number of employees in company: 50. Managing the product pipeline and portfolio, budgetting, growing sales (annual T/O 50M EUR) and gross margin of the portfolio of parallel imported RX pharmaceuticals to pharmacies as well as securing hospital tenders in across Scandinavian countries (DK, SE, and FI). In addition the role included market analysis and risk assessments (e.g. patent expiry), competitor analysis, market & price strategies and business… Show more Reported to Country Manager. Total number of employees in company: 50. Managing the product pipeline and portfolio, budgetting, growing sales (annual T/O 50M EUR) and gross margin of the portfolio of parallel imported RX pharmaceuticals to pharmacies as well as securing hospital tenders in across Scandinavian countries (DK, SE, and FI). In addition the role included market analysis and risk assessments (e.g. patent expiry), competitor analysis, market & price strategies and business development to secure growth. Show less

Reported to Managing Director. Total number of employees in company: 80. Active pharmaceutical ingredients development and commercial supply. Solid dosage form development. BD & sales in contract development (projects) for generics and new molecule drugs. Fostering- as well as expanding customer base, pursuit and implementation of operational objectives and business development by identifying new market opportunities. Long term attraction and binding of decision makers in pharmaceutical… Show more Reported to Managing Director. Total number of employees in company: 80. Active pharmaceutical ingredients development and commercial supply. Solid dosage form development. BD & sales in contract development (projects) for generics and new molecule drugs. Fostering- as well as expanding customer base, pursuit and implementation of operational objectives and business development by identifying new market opportunities. Long term attraction and binding of decision makers in pharmaceutical companies through professional and competent promotion and acquisition of development services and Active pharmaceutical Ingredient sales.Tasks also include:Intelligence gathering on customers and competitorsMarket analysis and business case compilation to support management decisions of future R&D activitiesBusiness model designMarketing and information management Show less

Reported to Managing Director. Total number of employees in company: 80. PharmaZell A/S was previously named GEA Pharmaceutical A/SActive pharmaceutical ingredients development and commercial supply. Solid dosage form development. BD and R&D contract development in Northern Europe & Scandinavian Region. Compile service proposals for solid dosage form development that could be translated on a scientific- and business level. Market analysis and business case compilation to support… Show more Reported to Managing Director. Total number of employees in company: 80. PharmaZell A/S was previously named GEA Pharmaceutical A/SActive pharmaceutical ingredients development and commercial supply. Solid dosage form development. BD and R&D contract development in Northern Europe & Scandinavian Region. Compile service proposals for solid dosage form development that could be translated on a scientific- and business level. Market analysis and business case compilation to support management decisions of future R&D activities.Promotion & Marketing sales activities Involvement in strategic planning and selection of key accounts Show less

Number of employees: 100 . Reported to BD Director. Business Development of R&D (Finished Dosage Form Development) for a Contract Manufacturing Organisation/Contract Research Organisation.

Executed a market research of the Chinese market. The work consisted of collecting relevant data of competitors, the developing market trends, and analyzing and identify market opportunities. The report was given to senior managers as a supplement to decision making.

Sales assistent, co-ordination of merchandicers in the field for a marketing campaign, handling promotion images for advertising purposes.